A-mansia is a Spin-Off from University catholique de Louvain (Prof Patrice Cani) and from Wageningen University (Prof Willem de Vos), A-mansia’s lead products include easy-to-use bacterial formulations to improve barrier function, gut health, and prevent development of metabolic syndromes.
Strong pre-clinical data are available and a first clinical investigation is currently ongoing. The developments have been partially financed. The creation of A-Mansia is supported by the Louvain Technology Transfer Office (LTTO) and Wageningen University.
In order to create and develop the spin-off company, we are looking for a (m/f):
Chief Executive Officer (CEO)
- High-Potential Microbiome Therapeutic Spin-off with a Global Ambition -
Main responsibilities:
After the successful closing of the 1st financing round, your main objective as a CEO is to set-up, to manage and to lead the development of the new A-Mansia company. This includes the following responsibilities:
Marketing & Sales:
· Propose and implement a market segmentation and product launch strategy.
· Develop a long term and a M&S portfolio strategy.
· Identify relevant collaborations and partnerships, licensing deals and business opportunities.
R&D & Operations:
· Coordinate the successful conclusion of the clinical developments.
· Manage the effective product registration worldwide.
· Scale-up and industrialize the production process from lab to industrial scale.
· Create a diversified portfolio of products and solutions to ensure the company’s future.
· Develop a lean way of working regarding operations and sub-contractors management.
Strategy & Finance:
· Propose to the board the adoption of a coherent and efficient strategic plan.
· Promote and execute the strategy with a focus on adding value for shareholders.
· Recruit, develop and manage a strong and experienced team with qualified skills.
· Implement a pro-active IP strategy as well as appropriate systems to mitigate risks.
· Communicate and promote positive relationships with all stakeholders.
Profile :
· You are PhD in biological sciences or equivalent. An additional MBA would be an asset.
· You have at least 10 years experience in comparable positions within the Biotech/Nutrition industry. To be experienced in market launch of similar products is also an advantage.
· You have a proven track record in interacting with regulatory international agencies.
· You take advantage of a professional network within the scientific community, the food ingredient and food supplement industry, and in the investor/financial community.
· You fluently communicate in English. Fluency in Dutch or French would be an asset.
· You demonstrate an excellent work ethic and you interact with subtlety.
· You show efficient leadership, interpersonal and negotiation skills.
· You have a proven entrepreneurial spirit.
Offer :
· A challenging position leading and developing a high-potential innovative spin-off company.
· The opportunity to promote and to develop a biotech company to the international scale.
· Varied contacts within the scientific world, the industry and investors’ community.
· An attractive package in line with the position responsibilities and its context.
· The opportunity to be remunerated under payroll or as a self-employed through your management company.
Would you be interested?
If yes, please send your CV together with an adapted cover letter via www.pahrtners.be/job/chief-executive-officer-ceo-2 or to .
Your application and related information you would share will remain strictly confidential.